Related Experiment Video
Updated: Aug 1, 2025

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes
Published on: March 12, 2013
Pro-arrhythmic effects of gain-of-function potassium channel mutations in the short QT syndrome
J C Hancox1,2, C Y Du1, A Butler1
1School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol BS8 1TD, UK.
Abstract:
The congenital short QT syndrome (SQTS) is a rare condition characterized by abbreviated rate-corrected QT (QTc) intervals on the electrocardiogram and by increased susceptibility to both atrial and ventricular arrhythmias and sudden death. Although mutations to multiple genes have been implicated in the SQTS, evidence of causality is particularly strong for the first three (SQT1-3) variants: these result from gain-of-function mutations in genes that encode K+ channel subunits responsible, respectively, for the IKr, IKs and IK1 cardiac potassium currents. This article reviews evidence for the impact of SQT1-3 missense potassium channel gene mutations on the electrophysiological properties of IKr, IKs and IK1 and of the links between these changes and arrhythmia susceptibility. Data from experimental and simulation studies and future directions for research in this field are considered. This article is part of the theme issue 'The heartbeat: its molecular basis and physiological mechanisms'.
Insights
Congenital short QT syndrome (SQTS) involves abbreviated QTc intervals, increasing arrhythmia risk. Gain-of-function mutations in potassium channel genes (SQT1-3) are strongly linked to this condition.
Area of Science:
- Cardiology
- Genetics
- Electrophysiology
Background:
- Congenital short QT syndrome (SQTS) is a rare inherited disorder.
- It is characterized by a shortened QT interval on ECG, predisposing individuals to life-threatening arrhythmias and sudden cardiac death.
- Mutations in several genes have been linked to SQTS, with strong evidence for SQT1-3 variants.
Purpose of the Study:
- To review the impact of SQT1-3 missense potassium channel gene mutations.
- To examine the effects on cardiac potassium currents (IKr, IKs, IK1) and electrophysiological properties.
- To explore the relationship between these genetic mutations, channel function, and arrhythmia susceptibility.
Main Methods:
- Review of experimental and simulation studies.
- Analysis of genetic mutations affecting potassium channel function.
- Correlation of electrophysiological changes with clinical outcomes.
Main Results:
- Gain-of-function mutations in KCNQ1, KCNH2, and KCNJ2 genes cause SQT1-3.
- These mutations alter the function of IKr, IKs, and IK1 potassium currents.
- Altered potassium currents are mechanistically linked to increased susceptibility to atrial and ventricular arrhythmias.
Conclusions:
- Missense mutations in potassium channel genes are causally linked to congenital short QT syndrome.
- Understanding these molecular mechanisms is crucial for diagnosing and managing SQTS.
- Further research is needed to explore therapeutic strategies and refine risk stratification.
Related Concept Videos
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Mechanism of Cardiac Arrhythmias
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...

